Stereotaxis (STXS)
(Delayed Data from AMEX)
$2.30 USD
-0.05 (-2.13%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $2.27 -0.03 (-1.30%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Income Statements
Fiscal Year end for Stereotaxis Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 27 | 28 | 35 | 27 | 29 |
Cost Of Goods | 12 | 10 | 12 | 8 | 6 |
Gross Profit | 15 | 18 | 23 | 19 | 23 |
Selling & Adminstrative & Depr. & Amort Expenses | 37 | 37 | 36 | 26 | 28 |
Income After Depreciation & Amortization | -22 | -19 | -13 | -7 | -5 |
Non-Operating Income | 1 | 0 | 2 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -21 | -18 | -11 | -7 | -5 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -21 | -18 | -11 | -7 | -5 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -21 | -18 | -11 | -7 | -5 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -22 | -18 | -13 | -7 | -5 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -22 | -19 | -13 | -7 | -5 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 80.70 | 76.06 | 75.56 | 72.75 | 63.05 |
Diluted EPS Before Non-Recurring Items | -0.27 | -0.26 | -0.16 | -0.11 | -0.10 |
Diluted Net EPS (GAAP) | -0.27 | -0.26 | -0.16 | -0.11 | -0.10 |
Fiscal Year end for Stereotaxis Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 4.57 | 7.80 | 7.86 | 6.55 |
Cost Of Goods | NA | 1.83 | 3.74 | 3.67 | 2.67 |
Gross Profit | NA | 2.74 | 4.06 | 4.19 | 3.88 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 8.04 | 9.70 | 9.47 | 9.50 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -5.30 | -5.64 | -5.28 | -5.62 |
Non-Operating Income | NA | 0.26 | 0.27 | 0.32 | 0.27 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -5.04 | -5.37 | -4.96 | -5.35 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -5.04 | -5.37 | -4.96 | -5.35 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -5.04 | -5.37 | -4.96 | -5.35 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 82.70 | 82.47 | 81.05 | 76.50 |
Diluted EPS Before Non-Recurring Items | NA | -0.07 | -0.07 | -0.07 | -0.07 |
Diluted Net EPS (GAAP) | NA | -0.06 | -0.07 | -0.07 | -0.07 |